Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seagen Inc.
  6. Revisions
    SGEN   US81181C1045

SEAGEN INC.

(SGEN)
  Report
Delayed Nasdaq  -  04:00 2022-09-28 pm EDT
137.72 USD   +1.75%
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK (tisotumab vedotin-tftv)
AQ
09/28Zai Lab Strikes Licensing Deal with Nasdaq-listed Seagen for Cervical Cancer Drug
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions